Semaglutide remains a common first GLP-1 path because coverage, familiarity, and prior response can make it the cleaner option
However, in 2023 the American Academy of Pediatrics (AAP) included GLP-1 medications in its new guidelines for pediatric obesity treatment, approving their use for children as young as 12
Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide, The Journal of Clinical Endocrinology & Metabolism 2025;110,(1)115
Mini Chicken Parmesan Bites (GLP-1 Friendly Comfort Food Recipe) Mini Chicken Parmesan Bites are high-protein, GLP-1 friendly comfort food in tiny portions
GLP-1 Complete by Vital Nutrients is a dietary supplement combining prebiotics, probiotics, postbiotics, and GLP-1 activators including hops extract formulated to support normal GLP-1 receptor activity, normal appetite regulation, normal blood glucose levels already within the normal range, normal digestive health, and normal gut barrier integrity as part of a balanced diet and healthy lifestyle

Proposed mechanisms of GLP-1RA-induced acute pancreatitis include pancreatic duct gland hyperplasia, pancreatic ductal obstruction leading to proinflammatory reactions, acinar cell hypertrophy, and pancreatic vascular injury.36 Additionally, another mechanism seen with the use of these drugs could be the increased risk of gallbladder or biliary diseases, especially when used in higher doses, for longer periods of time, and for weight loss.37 Previous animal studies suggested a risk of acute pancreatitis after GLP-1RA-based treatment.38 In addition, an initial analysis of the Food and Drug Administration's (FDA) adverse event reporting databases suggested an increased risk for acute pancreatitis with GLP-1RA-based therapy.39 It is important to note that this type of data analysis may not be the ideal method for comparing adverse event rates between medications